Phase 2 Low marrow blast count acute myeloid leukaemia (AML) Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Eltrombopag therapy for low platelets in patients on azacitidine treatment for myelodysplastic syndrome and acute myeloid leukaemia
Low marrow blast count acute myeloid leukaemia (AML)Myelodysplastic Syndromes (MDS)
Peter Mac Callum Cancer Centre25 enrolled1 locationACTRN12610000641099
Completed
Phase 2
Lenalidomide and 5azacitidine treatment versus 5azacitidine alone in patients with the blood cancers myelodysplastic syndrome or acute myeloid leukaemia
Low marrow blast count acute myeloid leukaemia (AML)
Australasian Leukaemia and Lymphoma Group160 enrolled1 locationACTRN12610000271000